A new study published today in The Lancet Oncology reports that for seven common cancer types (cancer of the oesophagus, stomach, colon, rectum, pancreas, lung, and ovary), survival has increased markedly across high-income countries over the period 1995–2014. The study was led by researchers from the International Agency for Research on Cancer (IARC) and undertaken within the International Cancer Benchmarking Partnership (ICBP).
Across the seven countries included in this ICBP study – Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the United Kingdom – the largest improvements over the 20-year period were observed in survival at 5 years after diagnosis for cancers of the colon and rectum.
This study from the Cancer Survival in High-Income Countries (SURVMARK-2) project is the latest cancer benchmark report of the ICBP, a global, multidisciplinary partnership of clinicians, academics, and policy-makers seeking to understand how and why cancer survival differs across countries with high-quality cancer registries as well as universal access to, and comparable expenditure on, health care.
Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson T, Myklebust TA, et al.
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
Lancet Oncol. Published online 11 September 2019;
Read the article